To further assess the predictive potential of CD3+ or CD8+ cell densities in different tumour regions (CT and PT), the patients were divided into two groups using the minimum P-value cut-off values for CD3 or CD8 densities in each tumour region (Cut-off values were 214, 375, 97, and 186 for CD3CT, CD3PT, CD8CT and CD8PT, respectively). The gene discussed is CD8A; the disease is neoplasm.